Key mutations discovered in cancer cells linked to WRN inhibitor resistance

Researchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibitors, a new class of anti-cancer drugs.

New protein identified as key to protecting kidneys in diabetic nephropathy

This study is led by Dr. Haisheng Zhou (Department of Biochemistry and Molecular Biology, Anhui Medical University, China) and Dr. Guoling Zhou (Center for Computational

February 24, 2025

Experts on AI Tell Nurses: ‘You Need to Embrace This’

WASHINGTON — Artificial intelligence (AI) in medicine certainly has advantages, but it’s not “magic,” experts warned, so it’s important for providers to understand the upside

October 10, 2023

New study reveals optimal drug sequencing for postmenopausal osteoporosis treatment

The effectiveness and safety of available sequential treatments for the long-term management of postmenopausal osteoporosis.

January 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.